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ABSTRACT 
Objective: This study was undertaken to formulate a floating drug delivery system of theophylline hydrochloride using different concentrations of a 
chosen polymer and then investigate how polymer concentration affects buoyancy and drug release properties of the tablets.  
Methods: Hydroxypropyl methylcellulose (HPMC) at different concentration levels of 15% (F1), 20% (F2) and 30% (F3) was used to form the three 
formulation batches of floating tablets. Wet granulation method was used for the granule preparation while Sodium bicarbonate and citric acid were 
used as the gas generating agent. The physical properties of the granules and the floating tablets were evaluated. Also determined were the 
physicomechanical properties, buoyancy and swelling characteristics of the tablets. The in vitro drug release study was carried out according to the 
USP I (basket method) for 8h in 900 ml 0.1N HCl at 50 rpm. Samples withdrawn at the regular predetermined time were analyzed 
spectrophotometrically at a wavelength of 271 nm and data obtained statistically analyzed by one-way analysis of variance (ANOVA). The 
differences between means were considered significant at P<0.05.  
Results: The result showed that polymer (HPMC) concentration significantly (p>0.05) increased swelling index and improved floating lag time, it 
had no significant effect on the total floating time. Percentage drug release at the end of 8 h was 100%, 98.2% and 96.13% for formulation F1, F2 
and F3, respectively. All three formulations followed the Higuchi drug release kinetics model and the mechanism of drug release was the non 
Fickian diffusion with exponents of 0.46, 0.51 and 0.56 for the respective batch. 
Conclusion: Batch F3 gave a better-controlled drug release and floating properties in comparison to batch F1 and F2 thus Polymer concentration 
influenced the onset of floating and controlled the release of Theophylline. 
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INTRODUCTION 
Oral delivery is the most popular route of drug administration due to 
its versatility, ease of administration and patient compliance [1]. 
Drugs with short half-lives and that are easily absorbed from the 
gastrointestinal tract (GIT) are, however, eliminated quickly from 
systemic circulation after oral administration. To achieve and 
maintain the concentration of these types of drugs within the 
effective therapeutic range, it is often necessary to frequently 
administer the drug with resultant fluctuation levels in the plasma 
[2]. To avoid this limitation, the development of oral modified 
(sustained) release formulations is an attempt to release the drug 
slowly into the gastrointestinal tract and maintain an effective drug 
concentration in systemic circulation for a long time [3].  
After oral administration, sustained release dosage forms are retained 
in the gastrointestinal tract, releasing the drug in a controlled manner, 
so that its absorption sites in the tract are continuously supplied. 
These drug delivery systems nevertheless suffer mainly from two 
physiological events: (i) the unpredictable short gastric emptying time 
and (ii) the brief gastric retention time. These can result in incomplete 
drug release from the dosage form in the absorption region (stomach 
or upper part of the small intestine), leading to diminished efficacy of 
administered dose [3]. Gastric emptying of dosage forms is an 
extremely variable process, thus being able to influence the emptying 
time can be a valuable asset for dosage forms that can reside in the 
stomach for a longer period of time than the conventional ones [4]. 
Many studies have been performed on gastro retentive delivery, an 
approach to achieve sustained release dosage forms of drugs having 
prolonged gastric residence time and this technique helps to improve 
site-specific targeting, increased solubility, better absorption and 
overall bioavailability of some poorly soluble of drugs such as 
theophylline, domperidone [5]. 
Theophylline is a methylxanthine derivative that is very effective in 
the treatment of chronic bronchial asthma and bronchospastic 
reaction. It has a narrow therapeutic concentration range (from 10-
20 µg/ml) with a short half-life, which necessitates frequent dosing 
with conventional dosage forms [6]. 
 
 
Fig. 1: Chemical structure of theophylline 
 
The toxicity of theophylline usually appears at a concentration above 
20 µg/ml and the fluctuations in its serum concentration can result in 
variability in the clinical response. Therefore, there is an obvious 
therapeutic need for a sustained release dosage form of theophylline, 
which will be able to maintain its therapeutic serum levels throughout 
24 h following a once or twice daily dose administration [7].  
Although several works have formulated theophylline floating 
delivery, many as directly compressible tablets, capsules, microbeads 
and as suspension, this original work was aimed at preparing 
sustained release effervescent floating tablet matrix of theophylline 
after wet granulation method and then determine the effect of HPMC 
concentration on ideal buoyancy and drug release [6, 8, 9]. 
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MATERIALS AND METHODS 
Materials 
Anhydrous Theophylline hydrochloride was purchased as a pure 
drug from Sigma-Aldrich, UK. Other excipients used were: HPMC 
(Hopkins and Williams Ltd, Stanheat Essex, England), Sodium 
bicarbonate, Stearic acid (BDH chemicals Poole, England) and citric 
acid (Philip Harris Ltd, Shenstone, England), magnesium stearate 
and talc obtained from (Shermen chemical Ltd, Sunderland and 
Sandy, England). Also, 95 % ethanol (Analar grade) was used. 
Method 
Preparation of granules 
The granules were prepared using the wet granulation method. 
Three batches of granules were prepared using the different 
concentrations of HPMC as the polymer. Batch 1 consisted of 10% 
polymer concentration (F1), a second batch (F2) and a third one 
(F3) consisted of 20% and 30% polymer concentration respectively. 
For batch 1 the ingredients (theophylline, sodium bicarbonate and 
citric acid) were weighed accurately and thoroughly mixed in a 
porcelain mortar. Granulation was done with a mixture of required 
HPMC in 95 % ethanol added to the powder mix in the mortar to 
form a wet mass. The wet mass was passed through a 2 mm sieve 
and the resulting granules dried in a conventional hot air oven 
(Techmel and Techmel, USA) at 60 °C for 2 h. The dried granules 
were then passed through a 1 mm sieve to obtain finer granules of 
uniform size. The same procedure was repeated for batch 2 and 3. 
Evaluation of theophylline granules 
Flow rate and angle of repose 
Angle of repose was determined using the fixed funnel method. A 
clean dry funnel was kept upright in a retort stand at a height 10 cm 
above a paper placed in a flat horizontal surface. The aperture of the 
funnel was blocked and 10 g of powder sample was poured into the 
funnel. Then the funnel was opened to release the powder onto the 
paper to form a conical heap. The height of the heap was measured 
by using a ruler and the diameter of the cone was also measured. 
The experiment was repeated three times for each batch of granules 
and the average was calculated. Angle of repose was calculated by 
using the equation (1). The flow rate of the granules was determined 
by recording the time taken for the 10 g of granules from each batch 
to flow through the fixed funnel suspended from the retort stand. 




 …………… (1) 
Where;  
h-height of heap and r-radius of the base of the powder 
 
Table 1: Composition of theophylline floating tablet 
Ingredients  F1  F2  F3 
Theophylline (mg) 
HPMC (%) 
Sodium bicarbonate (%) 
Citric acid (%) 
Stearic acid (%) 
























Bulk and tapped density 
A 10 g quantity of the granules was weighed and transferred into a 
100 ml graduated cylinder. The initial volume V was noted. The 
cylinder was mechanically tapped until no further reduction in 
volume was observed. The new volume V1 was noted. This 
determination was done in triplicate for each batch of granules and 
the average was calculated. The bulk and tapped densities were 
calculated using the equations below:  
	 =  
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Where Bd is bulk density, Td the tapped density, W is the weight of 
granule and V is bulk volume and is the tapped volumeV1. 
Hausner’s ratio and carr’s compressibility index 
These values were calculated as the ratios given below for each 
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Where Td = of granules and Bd = of granule 
Determination of granule density  
The fluid displacement method using a pycnometer was used. A 25 
ml pycnometer was weighed and the weight was noted, thereafter 
the pycnometer bottle was filled with xylene and the excess was 
wiped off. The filled bottle was reweighed, and the difference 
between this new weight and the weight of the empty pycnometer 
bottle was calculated. A 1g quantity of each batch of granule was 
transferred into the pycnometer bottle. The excess xylene was 
wiped off and the bottle was weighed again. The granule density was 






Ds is the density of non-solvent (Xylene), Ws is the weight of granule 
sample, W1 is the weight of pycnometer+solvent and W2 is the 
weight of pycnometer+sample+solvent 
Granule porosity and packing fraction of the granules 
The porosity and packing fraction of each batch of granules were 
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Compression of theophylline tablets 
The prepared granules were lubricated with 5 % stearic acid, 1 % 
magnesium stearate and 1 % talc, and compressed into tablets using 
a single punch tableting press fitted with 12.5 mm flat-faced 
punches (Cadmach, India) at a constant compression force of 15kN. 
Evaluation of theophylline floating tablets 
Weight uniformity test 
Twenty (20) tablets were randomly selected from each batch and 
individually weighed using an electronic balance (Ohaus, Galaxy). 
The mean, standard deviation and coefficient of variation were 
calculated. 
Crushing strength and friability 
The crushing strength of the tablets was determined using the 
Monsanto hardness tester (Rolex, Chandigarh). Ten tablets from 
each batch were randomly selected and tested and the average 
calculated. The friability of 5 tablets was measured in a Roche 
friability apparatus (UNID 056830 Campbell Electronic, Mumbai, 
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India). The tablets were dusted and weighed (Wo) and before being 
placed in the friabilator, which was then operated at a speed of 25 
rpm for 4 min. Then the tablets were removed from the chamber 
dusted and reweighed (W1). The friability was then calculated using 
the equation below:  
,-./0.1..23 = ) −
!
!
+ ×  …………… (9) 
Where, W0 is the initial weight of tablets before the test, W1 is the 
final weight of tablets after the test. 
Thickness and diameter 
The thickness of each of 10 randomly selected tablets was 
determined using the micrometer screw gauge (KFW Scientific 
Industries Ambala Cantt, India) and the average thickness was 
calculated. 
The diameter of each of 10 tablets from each batch was randomly 
selected and their individual diameter was determined using the 
micrometer screw gauge (KFW Scientific Industries Ambala Cantt, 
India) and the average diameter was calculated. 
Tablet porosity: The tablet porosity was calculated using the 
Equation below;  
4 (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Where m is mean weight of tablets, ρ is particle density, r is mean 
tablet radius and h is tablet thickness. 
Swelling index 
One tablet from each batch was weighed before placing them in a Petri 
dish containing 0.1N HCl. At 30 minute intervals, the swollen tablets 
were taken out and weighed after mopping off the fluid medium from 
the swollen tablets using a blotting paper. The swelling index of the 
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Where, SI-swelling index, Wt-weight of tablet at time t, W0-initial 
weight of the tablet 
In vitro buoyancy studies 
One tablet from each formulation was placed in 250 ml beaker 
containing 0.1N HCl. The time taken by the tablet to move from the 
bottom of the beaker to the top and float was noted and recorded as 
the floating lag time. The time for which the tablet remained floating 
on the surface was noted and recorded as the total floating time. The 
determination was carried out in triplicates and the average 
calculated. 
Standard calibration curve of theophylline in 0.1N HCl 
A 50 mg quantity of theophylline powder was dissolved in 30 ml of 
0.1N HCl. The resultant solution was transferred to 50 ml volumetric 
flask and made up to volume with 0.1N HCl. Serial dilutions of 2 
µg/ml, 4 µg/ml, 6 µg/ml, 8 µg/ml, 10 µg/ml and 12 µg/ml were 
prepared, and their absorbances were read in a UV-
spectrophotometer (UNICO-spectrophotometer, UV-2100 PC, 
Shanghai Instrument Co., China) at a wavelength of 271 nm. Graphs 
of absorbance versus concentration were plotted to obtain the 
calibration curves of theophylline in 0.1N HCl. 
Absolute drug content of theophylline tablets 
Ten pre-weighed tablets from each batch were crushed in a mortar. 
A powdered quantity equivalent to 200 mg was weighed out and 
dissolved in 100 ml of 0.1N HCl in a volumetric flask. The solution 
was filtered using a Whatman filter paper no.2, 0.1 ml of the filtrate 
was then measured and diluted up to 10 ml with 0.1N HCl and 
analyzed spectrophotometrically at 271 nm using 0.1N HCl as blank. 
The concentration of theophylline was then obtained by using the 
standard calibration curve of theophylline.  
In vitro drug release study of theophylline floating tablets 
Drug release study was carried out according to USP I (basket) 
method. The dissolution studies were conducted with dissolution 
apparatus (RCZ-6C3, China). The dissolution medium was 900 ml of 
0.1N HCl, maintained at a temperature of 36±0.5 °C. The agitation of 
the medium was maintained at 50 rpm. 10 ml aliquots were 
withdrawn at 30 min interval up to 8 h and replaced each time with 
an equivalent of 10 ml of the dissolution medium maintained at the 
same temperature. The withdrawn samples were filtered through a 
Whatman filter paper no.2, diluted appropriately and then analyzed 
spectrophotometrically at a wavelength of 271 nm using UNICO–
spectrophotometer (UV-2100PC Shanghai instrument Co. Ltd., 
China) and cumulative percentage drug release was calculated. 
In vitro kinetic release studies of theophylline floating matrix 
tablets 
Data obtained from dissolution studies were subjected to release 
kinetics evaluation to determine which model most appropriately 
describes it.  
The model with the highest correlation coefficient (R2) was 
considered to be the best fit for the designated kinetic release. 
Mechanism of drug release from theophylline sustained release 
matrix tablets 
The likely mechanism of drug release was determined by plotting 
the percentage drug release fitted into Korsemeyer-Peppas model 
equation.  
Statistical analysis  
All experiments were carried out in triplicates and the results 
expressed as mean±SD. The data obtained were subjected to 
analysis of variance (ANOVA) and differences between means were 
considered significant at P<0.05. 
 
RESULTS AND DISCUSSION 















F1 0.34±0.00 0.40±0.00 14.51±0.26  1.17±0.01 30.40±1.31 2.06±0.34 
F2 0.34±0.00 0.40±0.01 12.90±2.80  1.16±0.00  31.40±0.71 3.03±0.38  
F3 0.30±0.00 0.35±0.00 15.47±0.39  1.18±0.01  28.00±0.90 3.87±0.13 
KEY. Result is presented as mean±standard deviation and number of times (n) =3. 
 
Table 3: Physical properties of theophylline floating tablet matrix 







(kg/f) n =10 
Friability 
(%) n=5 
Drug content (%) 
F1 0.41±0.01 (2.2%) 3.14±0.11 12.23±0.09 4.34±0.32  0.95 99.50 
F2 0.41±0.01 (2.4%) 3.13±0.04 12.23±0.14 4.44±0.32  0.93 99.80 
F3 0.41±0.01(2.5%) 3.23±0.08 12.21±0.12 4.52±0.31  0.86 98.80 
Result is presented as mean±standard deviation and number of times (n) =3. 
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Table 4: Other properties of theophylline granules and floating tablets 
Batch code Granule density (g/ml) Granule porosity (%) Packing fraction Tablet porosity (%) 
F1 1.33±0.01 74.30±0.01 0.26±0.01 58.20 
F2 1.28±0.01 73.44±0.01 0.27±0.01 56.60 
F3 1.10±0.00 72.70±0.00 0.28±0.00 51.10 
 
Micromeritic and flow properties of theophylline granules 
The result of the micrometric and flow properties of granules is 
presented in table 2. From the result, there was an observed 
increase in the density from bulk density to tapped density. This 
results from the densification of the granules as a result of the 
tapping process. Tapping affects the packing of pharmaceutical 
powders and granules, causing a rearrangement in the bulk and 
leading to a reduction in the volume occupied by the 
granules/powder in the container [10]. Also, it was observed that 
the bulk and tapped densities decreased with an increase in polymer 
concentration. This observation is consistent with the formation of 
larger granules as the concentration of the polymer increases 
leading to larger voids in between larger granules. This is due to the 
increase in the formation of bonds between the theophylline 
particles and the polymer [11]. 
Hausner’s ratio, angle of repose and Carr’s index are indirect means 
of assessing the flow properties of granules. From the results 
obtained, the Carr’s index ranged from 12.90 % to 15.470 %, and 
Hausner’s ratio ranged from 1.160 to 1.180, indicating good flow 
property. The values for the angle of repose obtained were between 
28.0 ° to 31.4 ° indicating flow property rated excellent to good [1]. 
Batch F1 and batch F3 with angle of repose values of 28.0 ° and 30.4 
° respectively possessed excellent flow properties while batch F2 
possessed good flow property. 
The flow rate, a direct measure of assessing flow property, ranged 
from 2.06 g/s to 3.87 g/s, with batch F1 possessing flow rate of 2.06 
g/s and batch F2 with a flow rate of 3.03 g/s while batch F3 had a 
flow rate of 3.87 g/s. From the result, there was an observed 
increase in flow rate with an increase in polymer concentration. 
Increase in polymer concentration resulted in a significant 
difference (p<0.05) in the flow rate. 
Physical properties of theophylline floating tablet  
The result of the physical properties of tablets produced with the 
different proportions of HPMC is presented in the table 3. From the 
result, the crushing strength of the tablets was in the range of 4.34 to 
4.52 kg/f, the weight variations of the tablets of all the formulation 
was less than 5 %. The friability of all the formulations was in the 
range of 0.86 % to 0.95 %. Tablet thickness and diameter was in 
range of 3.13 mm to 3.23 mm and 12.21 mm to 12.23 mm 
respectively. Absolute drug content of all the formulations were 
found to be in range of 95.50% to 99.80%. Floating lag time ranged 
from 52 seconds to 123 seconds. Total floating time was>24 h for 
batch F1, F2 and F3. 
Weight uniformity test is a pharmacopoeial test which ensures 
consistency of dosage units during compression. The weight 
uniformity test indicated no significant difference (P>0.05) in the 
weights of tablets from batch F1 to F3 and hence conformed to the 
specification of the British Pharmacopoeia [12]. 
Although there was no significant difference (p>0.05) amongst the 
tablet dimensions (thickness and diameter), tablet hardness was 
between 4.34 kg/f and 4.54 kg/f for all formulation. Tablet hardness 
affects parameters like tablet disintegration, dissolution as well as 
the buoyancy properties of the tablet [13]. There was no significant 
difference (p>0.05) in the tablet hardness in the different 
proportions of the polymer used. However hardness exerts an effect 
on the floating of the tablets. This is because hardness influences the 
compaction of substances in the tablets, the higher the hardness, the 
higher the compaction. A higher compaction decreases the porosity 
of the tablet matrix causing a retardation of solvent penetration into 
the tablet core [15]. In fact Kiatissak et al., (2007) had reported that 
tablets with hardness of 8 kg/cm2 showed no floating capability.  
The friability of all the formulations was in the range of 0.86 % to 
0.96 %. The test of friability measures the ability of the tablet to 
withstand abrasion during packing, handling and shipping. The 
normal limits for tablet friability is less than or equal to 1 % [12]. 
From the result of the study, the friability loss for all formulation 
was found to be within this stipulated limit. There was an observed 
decrease in tablet friability as the proportion of the polymer 
increases. The increased resistance of the matrices to fracture and 
abrasion as the polymer concentration increased could be attributed 
to the formation of more solid bonds [16]. 
The results of drug content for batch1, batch 2 and batch 3 were 
99.50 %, 98.80 % and 99.8 % respectively. These results are within 
the official limits [17], indicating proper mixing and processing of all 
the three batches. 
Other properties of theophylline granules and floating tablets 
The result of granule density, packing fraction, granule porosity and 
tablet porosity of theophylline floating tablets is shown in table 4. 
From the result, the granule density ranged from 1.10 g/ml to 1.33 
g/ml, packing fraction ranged from 3.66 to 3.89; granule porosity is 
in the range of 72.70 % to 74.30 %, while tablet porosity ranged 
from 51.10 % to 58.20 %. 
There was no significant difference (p>0.05) in the granule density, 
granule porosity and packing fraction with an increase in polymer 
concentration. There was an observed decrease in porosity from 
granule to tablet; this is due to the compression of the granules 
during the tableting process which results in a reduction in porosity 
[18]. There was an observed increase in packing fraction with a 
decrease in granule porosity. 
Porosity is a good predictor of how liquids enter into the tablet matrix; 
it also influences but not exclusively drug dissolution rate as other 
factors like solubility, surface area, particle size and polymer type play 
a role too [19]. There was no significant difference (p>0.05) in the 
tablet porosity with increase in polymer concentration, however, there 
was a slight decrease in tablet porosity with increase in the polymer 
concentration. Spath et al., (2015) reported that an increase in binder 
concentration results in a reduction in tablet porosity as more of the 
inter particulate voids were filled with the binder/polymer solution. 
Tablets with low porosity retards the penetration of the medium into 
the tablet resulting in decrease drug release rate and prolong the 
floating lag time [19]. In this study, the tablet with the least porosity 
exhibited the shortest floating lag time. This may be due to the 
polymer content. It has been reported that unlike hydrophobic 
polymers such as ethylcellulose, in tablets formulated with hydrophilic 
polymers such as HPMC, tablet porosity may not be a critical factor for 
medium uptake by the tablet because of the polymers capability to 
absorb the test medium due to its hydrophilic property [21]. The 
swelling index study confirms this. Also in this study, a direct 
relationship was observed between tablet porosity and drug release 
rate, as the drug release rate decreases with a decrease in tablet 
porosity. Higher levels of polymer correspond to a lower porosity of 
the matrix tablet and a slower drug release rate can be achieved [22]. 
Swelling index and in vitro buoyancy studies 
The swelling index study measures the hydration ability of the 
tablet. It influences tablet buoyancy, swelling behavior and drug 
release kinetics [23]. The result (fig. 3) shows that the swelling index 
increased with an increase in polymer concentration and contact 
time with the dissolution medium. The hydrophilic nature of the 
HPMC may have contributed to this observation with a sustained 
index after about 3hours likely signaling point of complete polymer 
hydration. From the result, the floating lag time ranges from 52 
seconds to 123 seconds whereas the total floating time was>24 h for 
each batch, and during this time, the size of the swollen matrix gel 
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reduced because of disintegration and erosion. It was also observed 
that some of the gas generated from the tablet on hydration in the 
dissolution medium, was retained within the gel, thus decreasing the 
density of the tablet below 1.2 g/cm3, and conferring buoyancy to 
the tablet. This was seen in tablets not disintegrating. Previous 
studies showed that tablets with a density greater than 1.004 g/cm3 
could not float on gastric fluid. A floating system is better with a 
shorter floating lag time (as seen in batch F3) so that the tablet may 
not attach to the lower part of the stomach impeding buoyancy, and 
suffering the physiological consequence of gastric emptying [1]. 
 
Table 5: Effect of HPMC concentration on the buoyancy property of the floating tablet 
Batch code Floating lag time (FLT) (s) n=3 Total floating time (TFT) (h) 
F1 123±4.71 >24 
F2 77±4.98 >24 
F3 52±2.05 >24 
 
The increase in the concentration of the polymer did not have any 
significant effect (p>0.05) on the total floating time. However, the 
different proportions of the HPMC in the different batches had a 
significant effect (p<0.05) on the floating lag time as increased 
concentration of polymer resulted in decreased floating lag time. 
One possible reason could be related to the swelling index study, 
whereby the tablet with a higher proportion of the polymer 
exhibited more polymer hydration per time with the high swelling 
index value at any time compared to the tablet having lower 
polymer concentration. The rapid hydration of the polymer results 
in the formation of a gelatinous layer when in an aqueous medium. 
This gelatinous layer reduces the escape of generated gas from the 
tablet matrix thereby decreasing the density of the tablet which 
leads to the floating of the tablet within a short period of time [24]. 
  
  
a. Tablet at initial time b. Tablet begins to float 
  
c. Tablet midway the medium d. Tablet at the top of the medium 
Fig. 2: Photographs of in vitro floating behavior of theophylline floating tablet 
 
In vitro dissolution studies 
The release profile revealed that an increase in polymer 
concentration reduces the percentage of drug released. The increase 
in hydrophilic polymer proportion results in increase viscosity of the 
tablet matrix gel layer after hydration of the polymer as well as the 
formation of a gel layer with a longer diffusional path [25]. This 
phenomenon could explain the decrease in effective diffusion of the 
drug out of the gel and a consequent reduction in the rate of drug 
release.  
The percentage drug release at the end of 8 h was 100 %, 98.2 % and 
96.13 % for formulation batches F1, F2 and F3 respectively. The 
drug release was sustained for 8 h for all the batches.  
However, there was an observed faster onset of drug release initially 
with a subsequent decrease in the release rate with time. 
Hydrophilicity of the polymer promotes the wetting of the tablet 
matrix with a burst release of the drug at the initial stage of 
hydration, then controlled release follows due to the viscous gel 
mass of the tablet polymer retarding drug release [24]. 
  
Table 6: Release kinetics of theophylline floating tablet 
Batch code    R²  Diffusion exponent(n) 
Zero order First order Higuchi model Korsemeyer model 
F1 0.856 0.507 0.975 0.976 0.46 
F2 0.864 0.278 0.973 0.975 0.51 
F3 0.883 0.205 0.972 0.974 0.56 
 
Release kinetics and mechanism of release of theophylline 
floating tablets  
The result of the in vitro release kinetics and mechanism of release of 
theophylline floating tablets is presented in table 6. The regression 
values indicate that all the batches (F1, F2 and F3) followed Higuchi 
model of release kinetics. Thus the drug release is directly proportional 
to the square root of time, indicating that the drug release is diffusion 
controlled. Furthermore, the drug release data were fitted into the 
Korsemeyer-Peppas model (table 6) and it revealed that the diffusion 
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mechanism involved in the drug release was non-Fickian diffusion type 
for F2 and F3 but fickian for F1. It has been reported that the release 
mechanism of drugs from HPMC matrix is by non-Fickian diffusion or 
anomalous transport involving both diffusion and matrix erosion [26]. 
Also, there was an observed increase in the value of the diffusion 
exponent (n) as the concentration of polymer increases. 
Release parameters of theophylline floating tablet 
The time is taken for 50 % and 90 % of theophylline to be released 
(t50 and t90) respectively were adopted to characterize the release of 
theophylline from the tablets. From the result presented in table 7, 
there was an observed increased in the time taken for 50 % and 90 
% of theophylline to be released with an increased in the polymer 
concentration. At high polymer content, the gel layer becomes 
stronger and more viscous bringing about a higher resistance to 
diffusion and matrix erosion. This consequently retards drug release 
thus prolonging the time taken for 50 % and 90 % of the drug to be 
released respectively [25].  
Also, higher polymer concentration increases the diffusion path 
length of the drug due to the formation of a greater amount of gel 
which retards drug release from the formulation. 
 
Table 7: Release parameters of theophylline floating tablets 
Batch code   t50 (h)  t90 (h) 
 F1  1.9  5.6 
 F2  2.2  6.0 
 F3  2.5  6.2 
 
CONCLUSION 
In conclusion, polymer concentration resulted in no significant 
difference (p>0.05) in granule density, granule porosity, packing fraction 
and tablet porosity. The increase in HPMC concentration from 15 % to 
30 % did not have a significant effect (p>0.05) on the total floating time 
of the tablets as all tablet batches remained floated for more than 24 h. 
However, the floating lag time (FLT) and swelling index were 
significantly affected (p<0.05) with higher HPMC concentration causing 
a reduction in the floating lag time but an increase in the swelling index 
of the tablet. An increase in the polymer concentration reduced drug 
release rate and followed the Higuchi model. While Batches F2 and F3 
followed non Fikian mechanism of release, F1 was in line with the Fikian 
type. Finally, Batch F3, containing 30 % of HPMC gave the best drug 
delivery and floating properties in comparison to the other batches, as it 
possessed the shortest floating lag time as well as gave a better control of 
the rate of drug release. 
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